- Report
- November 2025
- 270 Pages
Global
From €4463EUR$4,950USD£3,871GBP
- Report
- May 2026
- 140 Pages
Global
From €3606EUR$3,999USD£3,128GBP
- Report
- August 2025
- 189 Pages
Global
From €3197EUR$3,545USD£2,773GBP
€3552EUR$3,939USD£3,081GBP
- Report
- January 2026
- 185 Pages
Global
From €3197EUR$3,545USD£2,773GBP
€3552EUR$3,939USD£3,081GBP
- Report
- January 2026
- 184 Pages
Global
From €3197EUR$3,545USD£2,773GBP
€3552EUR$3,939USD£3,081GBP
- Report
- January 2026
- 183 Pages
Global
From €3197EUR$3,545USD£2,773GBP
€3552EUR$3,939USD£3,081GBP
- Report
- January 2026
- 197 Pages
Global
From €3197EUR$3,545USD£2,773GBP
€3552EUR$3,939USD£3,081GBP
- Report
- August 2025
- 180 Pages
Global
From €3197EUR$3,545USD£2,773GBP
€3552EUR$3,939USD£3,081GBP
- Report
- August 2025
- 185 Pages
Global
From €3197EUR$3,545USD£2,773GBP
€3552EUR$3,939USD£3,081GBP
- Report
- January 2026
- 185 Pages
Global
From €4058EUR$4,500USD£3,519GBP
- Report
- January 2026
- 180 Pages
Global
From €4058EUR$4,500USD£3,519GBP
- Report
- February 2026
- 250 Pages
Global
From €4049EUR$4,490USD£3,512GBP
- Report
- February 2026
- 250 Pages
Global
From €4049EUR$4,490USD£3,512GBP
- Report
- June 2026
- 384 Pages
Global
From €5275EUR$5,850USD£4,575GBP
- Report
- June 2026
- 372 Pages
Global
From €5275EUR$5,850USD£4,575GBP
- Report
- June 2026
- 444 Pages
Global
From €5275EUR$5,850USD£4,575GBP
- Report
- June 2026
- 268 Pages
Global
From €4914EUR$5,450USD£4,262GBP
- Report
- June 2026
- 548 Pages
Global
From €5275EUR$5,850USD£4,575GBP
- Report
- July 2025
- 181 Pages
Global
From €4058EUR$4,500USD£3,519GBP
- Report
- June 2025
- 400 Pages
Global
From €4462EUR$4,949USD£3,870GBP

Hemovigilance is a term used to describe the monitoring and surveillance of blood products and transfusions. It is an important part of the blood banking industry, as it helps to ensure the safety of blood products and transfusions. Hemovigilance involves the collection and analysis of data related to the safety of blood products and transfusions, as well as the identification of any potential risks. This data is then used to inform the development of safety protocols and procedures, as well as to identify any potential areas of improvement.
Hemovigilance is also used to monitor the quality of blood products and transfusions, as well as to ensure that they meet the necessary standards. This helps to ensure that the blood products and transfusions are safe and effective for use.
Some companies in the Hemovigilance market include Bio-Rad Laboratories, Grifols, and Immucor. Show Less Read more